Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 1;46(5):294-299.
doi: 10.1097/BRS.0000000000003750.

Surgery for Degenerative Cervical Myelopathy: What Really Counts?

Oliver Gembruch  1 , Ramazan Jabbarli  1 , Ali Rashidi  1   2 , Mehdi Chihi  1 , Susann Hetze  1 , Lennart Barthel  1 , Adrian Toplak  1 , Nicolai El Hindy  1   3 , Ulrich Sure  1 , Philipp Dammann  1 , Neriman Özkan  1
Affiliations

Surgery for Degenerative Cervical Myelopathy: What Really Counts?

Oliver Gembruch et al. Spine (Phila Pa 1976). .

Abstract

Study design: Retrospective study (data analysis).

Objective: The purpose of this study was to assess the role of different factors on postoperative outcome of patients with degenerative cervical myelopathy (DCM).

Summary of background data: Ongoing degenerative changes of DCM lead to progressive neurological deficits. The optimal timing of surgical treatment is still unclear, especially in patients with mild DCM.

Methods: Patients with DCM treated in our clinic between 2007 and 2016 were retrospectively analyzed. Pre- and postoperative neurological function was assessed by the modified Japanese Orthopaedic Association Score (mJOA Score) at different stages. The minimum clinically important difference (MCID) was used to evaluate the improvement after surgery. The comorbidities were recorded using the Charlson Comorbidity Index (CCI). Possible associations between age, sex, CCI, preoperative symptoms duration, high signal intensity (SI) on T2-weighted magnetic resonance imaging (MRI) with mJOA Score and MCID were analyzed using univariate analysis and multivariate regression models. Additionally, subgroup analysis was performed according to the severity of DCM (mild: mJOA Score ≥15 points; moderate: mJOA Score of 12-14 points; and severe: mJOA Score <12 points).

Results: The mean age of the final cohort (n = 411) was 62.6 years (range: 31-96 years), 36.0% were females. High SI on T2-weighted MRI was detected in 60.3% of the cases. In the multivariate analysis, patients' age (P = 0.005), higher CCI (P = 0.001), and presence of high SI on T2-weighted MRI (P = 0.0005) were associated independently with lower pre- and postoperative mJOA Score and postoperative MCID. Subgroup analysis revealed age and high SI on T2-weighted MRI as predictors of pre- and postoperative mJOA. However, symptom duration did not influence neurological outcome according to the severity of DCM.

Conclusion: Surgery for DCM leads to significant functional improvement. However, better outcome was observed in younger individuals with lower CCI and absence of radiographic myelopathy signs. Therefore, DCM surgery, particularly before occurrence of high SI on MRI, seems to be essential for postoperative functional improvement regardless the above-mentioned confounders.Level of Evidence: 3.

PubMed Disclaimer

Comment in

  • TO THE EDITOR.
    Kumar V, Rawat SS. Kumar V, et al. Spine (Phila Pa 1976). 2021 Oct 1;46(19):E1066. doi: 10.1097/BRS.0000000000004165. Spine (Phila Pa 1976). 2021. PMID: 34265809 No abstract available.
  • TO THE EDITOR.
    Gembruch O, Sure U, Özkan N. Gembruch O, et al. Spine (Phila Pa 1976). 2021 Oct 1;46(19):E1066-E1067. doi: 10.1097/BRS.0000000000004168. Spine (Phila Pa 1976). 2021. PMID: 34269763 No abstract available.

References

    1. Fehlings MG, Tetreault L, Nater A, et al. The aging of the global population: the changing epidemiology of disease and spinal disorders. Neurosurgery 2015; 77: (suppl 4): S1–S5.
    1. Nouri A, Tetreault L, Singh A, et al. Degenerative Cervical Myelopathy: Epidemiology, Genetics, and Pathogenesis. Spine (Phila Pa 1976) 2015; 40:E675–E693.
    1. Badhiwala JH, Ahuja CS, Akbar MA, et al. Degenerative cervical myelopathy—update and future directions. Nat Rev Neurol 2020; 16:108–124.
    1. Fehlings MG, Tetreault LA, Riew KD, et al. A clinical practice guideline for the management of patients with degenerative cervical myelopathy: recommendations for patients with mild, moderate, and severe disease and nonmyelopathic patients with evidence of cord compression. Global Spine J 2017; 7: (3 suppl): 70S–83S.
    1. Fehlings MG, Tetreault LA, Riew KD, et al. A clinical practice guideline for the management of degenerative cervical myelopathy: introduction, rationale, and scope. Global Spine J 2017; 7: (3 suppl): 21S–S27.